Neal Walker

Insider Reports History

Entity
Individual
Location
15 New England Executive Park, Burlington, MA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Neal Walker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. INTERIM PRESIDENT AND CEO, Director Common Stock 1.38M $2.88M $2.09 Nov 1, 2024 Direct
Aclaris Therapeutics, Inc. INTERIM PRESIDENT AND CEO, Director Restricted Stock Units 56.8K $67K $1.18 Nov 1, 2024 Direct
Aldeyra Therapeutics, Inc. Director Common Stock 15.9K $27.6K $1.74 Aug 22, 2023 Direct
Aclaris Therapeutics, Inc. INTERIM PRESIDENT AND CEO, Director Stock Option (Right to Buy) 497K Feb 1, 2024 Direct
Aldeyra Therapeutics, Inc. Director Stock Option (Right to Buy) 1.74K Jun 4, 2024 Direct
Aclaris Therapeutics, Inc. INTERIM PRESIDENT AND CEO, Director Employee Stock Option (right to buy) 0 Aug 9, 2024 Direct

Insider Reports Filed by Neal Walker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRS Aclaris Therapeutics, Inc. Nov 1, 2024 3 -$5.69K 4 Nov 5, 2024 INTERIM PRESIDENT AND CEO, Director
ACRS Aclaris Therapeutics, Inc. Oct 1, 2024 3 -$3.21K 4 Oct 3, 2024 INTERIM PRESIDENT AND CEO, Director
ACRS Aclaris Therapeutics, Inc. Sep 1, 2024 3 -$3.21K 4 Sep 4, 2024 INTERIM PRESIDENT AND CEO, Director
ACRS Aclaris Therapeutics, Inc. Aug 9, 2024 2 $31.4K 4 Aug 13, 2024 INTERIM PRESIDENT AND CEO, Director
ACRS Aclaris Therapeutics, Inc. Aug 1, 2024 3 -$3.59K 4 Aug 5, 2024 INTERIM PRESIDENT AND CEO, Director
ACRS Aclaris Therapeutics, Inc. Jul 1, 2024 3 -$3.13K 4 Jul 3, 2024 INTERIM PRESIDENT AND CEO, Director
ALDX Aldeyra Therapeutics, Inc. Jun 4, 2024 2 $0 4 Jun 6, 2024 Director
ACRS Aclaris Therapeutics, Inc. Jun 1, 2024 3 -$2.8K 4 Jun 4, 2024 INTERIM PRESIDENT AND CEO, Director
ACRS Aclaris Therapeutics, Inc. May 1, 2024 3 -$3.51K 4 May 3, 2024 INTERIM PRESIDENT AND CEO, Director
ACRS Aclaris Therapeutics, Inc. Apr 1, 2024 3 -$4.06K 4 Apr 3, 2024 INTERIM PRESIDENT AND CEO, Director
ACRS Aclaris Therapeutics, Inc. Mar 1, 2024 3 -$4K 4 Mar 5, 2024 Interim President and CEO, Director
ACRS Aclaris Therapeutics, Inc. Feb 1, 2024 2 $0 4 Feb 5, 2024 Interim CEO, Director
ALDX Aldeyra Therapeutics, Inc. Aug 22, 2023 2 $5.3K 4 Aug 24, 2023 Director
ALDX Aldeyra Therapeutics, Inc. Jun 30, 2023 2 $0 4 Jul 5, 2023 Director
ACRS Aclaris Therapeutics, Inc. Mar 1, 2023 10 -$741K 4 Mar 3, 2023 Director
ACRS Aclaris Therapeutics, Inc. Feb 1, 2023 5 -$500K 4 Feb 3, 2023 Director
ACRS Aclaris Therapeutics, Inc. Jan 3, 2023 3 -$605K 4 Jan 4, 2023 Director
ALDX Aldeyra Therapeutics, Inc. Jun 7, 2022 2 $0 4 Jun 9, 2022 Director
ACRS Aclaris Therapeutics, Inc. Apr 21, 2022 3 -$1.06M 4 Apr 25, 2022 President and CEO, Director
ACRS Aclaris Therapeutics, Inc. Mar 11, 2022 1 -$896K 4 Mar 14, 2022 President and CEO, Director
ACRS Aclaris Therapeutics, Inc. Mar 1, 2022 8 $0 4 Mar 3, 2022 President and CEO, Director
ACRS Aclaris Therapeutics, Inc. Feb 9, 2022 1 -$45.5K 4 Feb 11, 2022 President and CEO, Director
ACRS Aclaris Therapeutics, Inc. Feb 1, 2022 2 $0 4 Feb 3, 2022 President and CEO, Director
ALDX Aldeyra Therapeutics, Inc. Jun 8, 2021 2 $0 4 Jun 10, 2021 Director
ACRS Aclaris Therapeutics, Inc. Jun 1, 2021 4 -$720K 4 Jun 2, 2021 President and CEO, Director